Press Release
Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs Canalevia®-CA1, Jaguar's first-generation antisecretory drug for the treatment of chemotherapy-induced diarrhea in dogs, has received extension of conditional approval by FDA Read More
Press Release
Latin America’s Healthcare IT Market Surges: Black Book Highlights $10.2 Billion Growth Opportunity and Top Consulting Firms Leading Digital Transformation
Ten consulting firms have been recognized by clients for delivering top-rated outcomes in Latin America's rapidly growing healthcare IT market. As the region's digital transformation accelerates, these firms are leading the way in implementing EHRs, telehealth platforms, population health and advanced analytics solutions. Read More
Press Release
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's disease Expanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's Read More
Press Release
Upwind Secures $100M Series A to Power Cloud Infrastructure Security with Next-Generation Runtime Technology
With enterprises rapidly moving sensitive information to the cloud, Upwind's next-generation cloud security platform helps organizations prioritize critical risks and fix them faster. Read More
Press Release
